Literature DB >> 22483683

A C-terminal interdomain disulfide bond significantly stabilizes the Fc fragment of IgG.

Gordana Wozniak-Knopp1, Florian Rüker.   

Abstract

We describe the stabilization of human IgG1 Fc by an engineered interdomain disulfide bond at the C-terminal end of the molecule. Covalently interconnecting the C-termini of the CH(3) domains led to an increase of the melting temperatures by 5.6 and 9.1 °C respectively as compared to CH(3) domains in the context of the wild-type Fc. Combined with a recently described additional intradomain disulfide bond, both novel disulfide bonds led to an increase of the Tm by about 18.1 °C to 100.7 °C. The interdomain disulfide bond had no impact on the thermal stability of the CH(2) domain. Far- and near-UV CD spectroscopy showed very similar overall CD profiles, indicating that secondary and tertiary structure of the Fc was not negatively affected. When introduced into an Fc fragment that had been engineered to bind to Her2/neu via a novel antigen binding site located at the C-terminus of the CH(3) domain, the novel inter- and intra-domain bonds also brought about a significant increase in thermostability. Using them in combination, the Tm of the CH(3) domain was raised by 18 °C and thus restored to the Tm of the wild-type CH(3) domain. Importantly, antigen binding of the modified Fc was not affected by the engineered disulfide bonds.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483683     DOI: 10.1016/j.abb.2012.03.024

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.

Authors:  Fang Zeng; Chunpeng Yang; Xinyu Gao; Xuan Li; Zhe Zhang; Rui Gong
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

2.  Stability assessment on a library scale: a rapid method for the evaluation of the commutability and insertion of residues in C-terminal loops of the CH3 domains of IgG1-Fc.

Authors:  Christoph Hasenhindl; Michael W Traxlmayr; Gordana Wozniak-Knopp; Phil C Jones; Gerhard Stadlmayr; Florian Rüker; Christian Obinger
Journal:  Protein Eng Des Sel       Date:  2013-09-04       Impact factor: 1.650

3.  Creating stable stem regions for loop elongation in Fcabs - insights from combining yeast surface display, in silico loop reconstruction and molecular dynamics simulations.

Authors:  Christoph Hasenhindl; Balder Lai; Javier Delgado; Michael W Traxlmayr; Gerhard Stadlmayr; Florian Rüker; Luis Serrano; Chris Oostenbrink; Christian Obinger
Journal:  Biochim Biophys Acta       Date:  2014-05-02

Review 4.  Engineered IgG1-Fc--one fragment to bind them all.

Authors:  Elisabeth Lobner; Michael W Traxlmayr; Christian Obinger; Christoph Hasenhindl
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

5.  Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains.

Authors:  Filippo Benedetti; Florian Stracke; Gerhard Stadlmayr; Katharina Stadlbauer; Florian Rüker; Gordana Wozniak-Knopp
Journal:  Biochem Biophys Rep       Date:  2021-02-27

Review 6.  Engineering Strategies to Overcome the Stability-Function Trade-Off in Proteins.

Authors:  Magdalena Teufl; Charlotte U Zajc; Michael W Traxlmayr
Journal:  ACS Synth Biol       Date:  2022-03-08       Impact factor: 5.249

Review 7.  Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.

Authors:  Chunpeng Yang; Xinyu Gao; Rui Gong
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

8.  An antibody with Fab-constant domains exchanged for a pair of CH3 domains.

Authors:  Gordana Wozniak-Knopp; Gerhard Stadlmayr; Jan Walther Perthold; Katharina Stadlbauer; Mathias Gotsmy; Stefan Becker; Florian Rüker
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.